In a sultry basement bar on a Wednesday night in downtown Manhattan, some serious trash talking was going on. “No pity, bitches!” said attorney and former prosecutor Frances Impellizzeri to her three ...
Warren Buffett, born in Omaha in 1930, studied at the University of Nebraska and Columbia Business School, and took control of Berkshire Hathaway in 1965, turning a struggling textile company into his ...
Genevieve's jaw drops as she uncovers two hidden idols—only to realize she can't use either one! Giuliani's diagnosis revealed as Trump ally remains in critical condition Princess Charlotte rings in ...
Its publisher, Hachette, will not release the novel in the United States and will discontinue its U.K. edition, citing its commitment to “original creative expression and storytelling.” By Alexandra ...
For decades scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years of probing work and extensive experimentation, a Yale research team has ...
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...
Software engineering was supposed to be artificial intelligence’s easiest win. Today companies such as OpenAI, Anthropic, Microsoft and Google have all released AI products geared specifically to ...
Developers are using a new geothermal technology in Germany to produce clean energy. Detail of the teeth of a drill bit that will be used in the next phase of drilling. Credit...Roderick Aichinger for ...
NASHVILLE, Tenn. (WKRN) — Wednesday, Gov. Bill Lee announced the green light for The Boring Company to move forward with the Music City Loop. According to the Governor’s Office, the Tennessee Highway ...
This week, Palantir announced on X it’s relocating its headquarters to Miami. Plus, a look at the controversy around Ring's Search Party feature. But first, an update to Google's AI search summaries.
— Finding Hope for FRRS1L plans to initiate clinical trial using TfR1 CapX gene therapy in the second half of 2026, pending regulatory review — FORT COLLINS, Colo. and NEW YORK, Feb. 18, 2026 ...